Skip to main navigation Skip to search Skip to main content

CTIM-32. IMMUNE CHECKPOINT INHIBITOR NIVOLUMAB IN PEOPLE WITH RECURRENT SELECT RARE CNS CANCERS: RESULTS OF INTERIM ANALYSIS IN A HEAVILY PRETREATED COHORT

  • Marta Penas-Prado
  • , Ying Yuan
  • , Kathleen Wall
  • , Elizabeth Vera
  • , Ukeme Ikiddeh-Barnes
  • , Katie Blackburn
  • , Claudia Chambers
  • , Nivi Ratnam
  • , Stephen Frederico
  • , Alvina Acquaye
  • , Kenneth Aldape
  • , Nicole Briceno
  • , Anna Choi
  • , Alexa Christ
  • , Varna Jammula
  • , Heather Leeper
  • , Jason Levine
  • , Matthew Lindsley
  • , Jennifer Reyes
  • , Kayla Roche
  • James Rogers, Michael Timmer, Lisa Boris, Eric Burton, Nicole Lollo, Marissa Panzer, Lily Polskin, Valentina Pillai, Martha Quezado, Brett Theeler, Jing Wu, Terri Armstrong, Mark Gilbert

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
Pages (from-to)vi57-vi58
JournalNeuro-Oncology
Volume23
Issue numberSupplement_6
DOIs
StatePublished - Dec 2021

Fingerprint

Dive into the research topics of 'CTIM-32. IMMUNE CHECKPOINT INHIBITOR NIVOLUMAB IN PEOPLE WITH RECURRENT SELECT RARE CNS CANCERS: RESULTS OF INTERIM ANALYSIS IN A HEAVILY PRETREATED COHORT'. Together they form a unique fingerprint.

Cite this